Alzheimer's research & therapy
Increased levels of GFAP and purinergic P2X7 receptor in Alzheimer's disease brain are associated with Aβ, tau pathologies and synaptic loss.
Cinzia A Maschio, Oscar Moreno, Junlong Wang, Upasana Maheshwari, Annika Keller, Uwe Konietzko, Daniel Razansky, Agneta Nordberg, Axel Rominger, Christoph Hock, Jordi Llop, Roger M Nitsch, Ruiqing Ni
Published: 202510.1186/s13195-025-01916-2
No abstract available for this study.